TNFAIP8: A new effector for Galpha(i) coupling to reduce cell death and induce cell transformation

Journal of Cellular Physiology

Volumn 225, Issue 3, 2010, Pages 865-874

  Laliberté, Benoit ^a   Wilson, Ariel M ^a   Nafisi, Houman ^a   Mao, Helen ^a   Zhou, Yi Yuen ^a   Daigle, Mireille ^a   Albert, Paul R ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; BINDING PROTEIN; CASPASE; CYCLIC AMP; DOPAMINE 2 RECEPTOR; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; PROTEIN TIPE2; PROTEIN TIPEI; PROTEIN TNFAIP8; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTISENSE OLIGONUCLEOTIDE; APOPTOSIS REGULATORY PROTEIN; DOPAMINE D2L RECEPTOR; GNAI2 PROTEIN, MOUSE; GNAI3 PROTEIN, HUMAN; GNAI3 PROTEIN, MOUSE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; TNFAIP8 PROTEIN, MOUSE;

ANIMAL CELL; APOPTOSIS; ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CANCER GROWTH; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TWO HYBRID SYSTEM; YEAST; AMINO ACID SEQUENCE; ANIMAL; CELL DEATH; CELL STRAIN 3T3; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PROTEIN ANALYSIS; PROTEIN BINDING;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS REGULATORY PROTEINS; BALB 3T3 CELLS; CASPASES; CELL DEATH; CELL TRANSFORMATION, NEOPLASTIC; FLUORESCENCE RESONANCE ENERGY TRANSFER; GTP-BINDING PROTEIN ALPHA SUBUNIT, GI2; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HUMANS; IMMUNOPRECIPITATION; MICE; MOLECULAR SEQUENCE DATA; NIH 3T3 CELLS; OLIGONUCLEOTIDES, ANTISENSE; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; RECEPTORS, DOPAMINE D2; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 77957727123     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22297     Document Type: Article

References (40)

1. Albert PR. 1994. Heterologous expression of G protein-linked receptors in pituitary and fibroblast cell lines [Review]. Vit Horm 48: 59-109.
2. Albert PR. 2002. G protein preferences for dopamine D2 inhibition of prolactin secretion and DNA synthesis in GH(4) pituitary cells. Mol Endocrinol 16: 1903-1911.
3. Albert PR, Robillard L. 2002. G protein specificity. Traffic direction required. Cell Signal 14: 407-418.
4. Albert PR, Ghahremani MH, Morris SJ. 1997. Mechanisms of dopaminergic regulation of prolactin secretion. In: Neve KA, Neve RL, editors. The dopamine receptors. Totowa, NJ: Humana Press Inc. pp 359-381.
5. Albert PR, Sajedi N, Lemonde S, Ghahremani MH. 1999. Constitutive G(i2)-dependent activation of adenylyl cyclase type II by the 5-HT1A receptor. Inhibition by anxiolytic partial agonists. J Biol Chem 274: 35469-35474.
6. Ashkenazi A. 2008. Targeting the extrinsic apoptosis pathway in cancer. Cytokine Growth Factor Rev 19: 325-331.
7. Banihashemi B, Albert PR. 2002. Dopamine-D2S receptor inhibition of calcium influx, adenylyl cyclase, and mitogen-activated protein kinase in pituitary cells: Distinct Galpha and Gbetagamma requirements. Mol Endocrinol 16: 2393-2404.
8. Bockaert J, Claeysen S, Becamel C, Pinloche S, Dumuis A. 2002. G protein-coupled receptors: Dominant players in cell-cell communication. Int Rev Cytol 212: 63-132.
9. Dave RH, Saengsawang W, Yu JZ, Donati R, Rasenick MM. 2009. Heterotrimeric G-proteins interact directly with cytoskeletal components to modify microtubule-dependent cellular processes. Neurosignals 17: 100-108.
10. Debatin KM, Krammer PH. 2004. Death receptors in chemotherapy and cancer. Oncogene 23: 2950-2966.
11. Dorsam RT, Gutkind JS. 2007. G-protein-coupled receptors and cancer. Nat Rev Cancer 7: 79-94.
12. Ekert PG, Silke J, Vaux DL. 1999. Caspase inhibitors. Cell Death Differ 6: 1081-1086.
13. Ewing RM, Chu P, Elisma F, Li H, Taylor P, Climie S, McBroom-Cerajewski L, Robinson MD, O'Connor L, Li M, Taylor R, Dharsee M, Ho Y, Heilbut A, Moore L, Zhang S, Ornatsky O, Bukhman YV, Ethier M, Sheng Y, Vasilescu J, Abu-Farha M, Lambert JP, Duewel HS, Stewart II, Kuehl B, Hogue K, Colwill K, Gladwish K, Muskat B, Kinach R, Adams SL, Moran MF, Morin GB, Topaloglou T, Figeys D. 2007. Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol Syst Biol 3: 89.
14. Fredriksson R, Lagerstrom MC, Lundin L-G, Schioth HB. 2003. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 63: 1256-1272.
15. Gales C, Van Durm JJ, Schaak S, Pontier S, Percherancier Y, Audet M, Paris H, Bouvier M. 2006. Probing the activation-promoted structural rearrangements in preassembled receptor-G protein complexes. Nat Struct Mol Biol 13: 778-786.
16. Ghahremani MH, Forget C, Albert PR. 2000. Distinct roles for Galpha(i)2 and Gbetagamma in signaling to DNA synthesis and Galpha(i)3 in cellular transformation by dopamine D2S receptor activation in BALB/c 3T3 cells. Mol Cell Biol 20: 1497-1506.
17. Group INEW. 1985. Cellular and molecular mechanisms of cell transformation and standardization of transformation assays of established cell lines for the prediction of carcinogenic chemicals: Overview and recommended protocols. Cancer Res 45: 2395-2399.
18. Hamdan FF, Percherancier Y, Breton B, Bouvier M. 2006. Monitoring protein-protein interactions in living cells by bioluminescence resonance energy transfer (BRET). Curr Protoc Neurosci. Chapter 5: Unit 5, 23.
19. Horrevoets AJ, Fontijn RD, van Zonneveld AJ, de Vries CJ, ten Cate JW, Pannekoek H. 1999. Vascular endothelial genes that are responsive to tumor necrosis factor-alpha in vitro are expressed in atherosclerotic lesions, including inhibitor of apoptosis protein-1, stannin, and two novel genes. Blood 93: 3418-3431.
20. Jonkers J, Moolenaar WH. 2009. Mammary tumorigenesis through LPA receptor signaling. Cancer Cell 15: 457-459.
21. Kumar D, Whiteside TL, Kasid U. 2000. Identification of a novel tumor necrosis factor-alpha-inducible gene, SCC-S2, containing the consensus sequence of a death effector domain of fas-associated death domain-like interleukin-1beta-converting enzyme-inhibitory protein. J Biol Chem 275: 2973-2978.
22. Kumar D, Gokhale P, Broustas C, Chakravarty D, Ahmad I, Kasid U. 2004. Expression of SCC-S2, an antiapoptotic molecule, correlates with enhanced proliferation and tumorigenicity of MDA-MB 435 cells. Oncogene 23: 612-616.
23. Liu S, Umezu-Goto M, Murph M, Lu Y, Liu W, Zhang F, Yu S, Stephens LC, Cui X, Murrow G, Coombes K, Muller W, Hung MC, Perou CM, Lee AV, Fang X, Mills GB. 2009. Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases. Cancer Cell 15: 539-550.
24. Maeshima H, Ohno K, Tanaka-Azuma Y, Nakano S, Yamada T. 2009. Identification of tumor promotion marker genes for predicting tumor promoting potential of chemicals in BALB/c 3T3 cells. Toxicol In Vitro 23: 148-157.
25. Mao H, Zhao Q, Daigle M, Ghahremani MH, Chidiac P, Albert PR. 2004. RGS17/RGSZ2, a novel regulator of Gi/o, Gz, and Gq signaling. J Biol Chem 279: 26314-26322.
26. Miura D, Kobayashi M, Kakiuchi S, Kasahara Y, Kondo S. 2006. Enhancement of transformed foci and induction of prostaglandins in Balb/c 3T3 cells by palytoxin: In vitro model reproduces carcinogenic responses in animal models regarding the inhibitory effect of indomethacin and reversal of indomethacin's effect by exogenous prostaglandins. Toxicol Sci 89: 154-163.
27. Mochizuki N, Cho G, Wen B, Insel PA. 1996. Identification and cDNA cloning of a novel human mosaic protein, LGN, based on interaction with G alpha i2. Gene 181: 39-43.
28. Nafisi H, Banihashemi B, Daigle M, Albert PR. 2008. GAP1(IP4BP)/RASA3 mediates Galphai-induced inhibition of mitogen-activated protein kinase. J Biol Chem 283: 35908-35917.
29. Sethi G, Sung B, Aggarwal BB. 2008. TNF: A master switch for inflammation to cancer. Front Biosci 13: 5094-5107.
30. Siderovski DP, Willard FS. 2005. The GAPs, GEFs, and GDIs of heterotrimeric G-protein alpha subunits. Int J Biol Sci 1: 51-66.
31. Stephens BJ, Han H, Gokhale V, Von Hoff DD. 2005. PRL phosphatases as potential molecular targets in cancer. Mol Cancer Ther 4: 1653-1661.
32. Takesono A, Cismowski MJ, Ribas C, Bernard M, Chung P, Hazard S III, Duzic E, Lanier SM. 1999. Receptor-independent activators of heterotrimeric G-protein signaling pathways. J Biol Chem 274: 33202-33205.
33. Thorburn A. 2004. Death receptor-induced cell killing. Cell Signal 16: 139-144.
34. Whitaker GM, Accili EA. 2008. Using bioluminescence resonance energy transfer to measure ion channel assembly. Methods Mol Biol 491: 189-197.
35. Wise A, Jupe SC, Rees S. 2004. The identification of ligands at orphan G-protein coupled receptors. Annu Rev Pharmacol Toxicol 44: 43-66.
36. Woodward MJ, de Boer J, Heidorn S, Hubank M, Kioussis D, Williams O, Brady HJ. 2010. Tnfaip8 is an essential gene for the regulation of glucocorticoid-mediated apoptosis of thymocytes. Cell Death Differ 17: 316-323.
37. You Z, Ouyang H, Lopatin D, Polver PJ, Wang CY. 2001. Nuclear factor-kappa B-inducible death effector domain-containing protein suppresses tumor necrosis factor-mediated apoptosis by inhibiting caspase-8 activity. J Biol Chem 276: 26398-26404.
38. Zhang HG, Hyde K, Page GP, Brand JP, Zhou J, Yu S, Allison DB, Hsu HC, Mountz JD. 2004. Novel tumor necrosis factor alpha-regulated genes in rheumatoid arthritis. Arthritis Rheum 50: 420-431.
39. Zhang C, Chakravarty D, Sakabe I, Mewani RR, Boudreau HE, Kumar D, Ahmad I, Kasid UN. 2006. Role of SCC-S2 in experimental metastasis and modulation of VEGFR-2, MMP-1, and MMP-9 expression. Mol Ther 13: 947-955.
40. Zhang X, Wang J, Fan C, Li H, Sun H, Gong S, Chen YH, Shi Y. 2009. Crystal structure of TIPE2 provides insights into immune homeostasis. Nat Struct Mol Biol 16: 89-90.